Search by Drug Name or NDC

    NDC 60505-3096-02 Risedronate Sodium 75 mg/1 Details

    Risedronate Sodium 75 mg/1

    Risedronate Sodium is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is RISEDRONATE SODIUM.

    Product Information

    NDC 60505-3096
    Product ID 60505-3096_03428ba0-f6f3-be31-dc50-def19fdd4184
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Risedronate Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Risedronate Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 75
    Active Ingredient Units mg/1
    Substance Name RISEDRONATE SODIUM
    Labeler Name Apotex Corp.
    Pharmaceutical Class Bisphosphonate [EPC], Diphosphonates [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090877
    Listing Certified Through 2024-12-31

    Package

    NDC 60505-3096-02 (60505309602)

    NDC Package Code 60505-3096-2
    Billing NDC 60505309602
    Package 1 BLISTER PACK in 1 CARTON (60505-3096-2) / 2 TABLET, FILM COATED in 1 BLISTER PACK
    Marketing Start Date 2014-06-11
    NDC Exclude Flag N
    Pricing Information N/A